MALT Lymphoma

Also known as: MALT-lymphoma / Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] / Lymphoma, B-Cell, Marginal Zone / Mucosa-associated lymphoma (disorder) / Marginal zone B-cell lymphoma (morphologic abnormality) / Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (disorder) / Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (morphologic abnormality) / Primary cutaneous marginal zone B-cell lymphoma (disorder) / Primary cutaneous marginal zone B-cell lymphoma (morphologic abnormality) / Marginal zone lymphoma / Marginal zone lymphoma (disorder) / Bronchus-associated lymphoid tissue lymphoma / BALT lymphoma / Small cell B-cell lymphoma / Nodal marginal zone B-cell lymphoma (disorder) / Nodal marginal zone B-cell lymphoma / Monocytoid B-cell lymphoma (disorder) / Nodal marginal zone B-cell lymphomas / Nodal marginal zone B-cell lymphoma NOS / Nodal marginal zone B-cell lymphoma (morphologic abnormality) / Extranodal marginal zone B-cell lymphoma (MALT type) NOS / Extranodal marginal zone B-cell lymphoma (MALT type)

DrugDrug NameDrug Description
DB00291ChlorambucilA chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas.
DrugDrug NamePhaseStatusCount
DB06769Bendamustine2Completed1
DB00188Bortezomib2Completed1
DB16741Bortezomib D-mannitol2Completed1
DB00291Chlorambucil2Active Not Recruiting1
DB01234Dexamethasone2Completed1
DB01073Fludarabine2Completed1
DB00480Lenalidomide2Completed1
DB00480Lenalidomide2Unknown Status1
DB00073Rituximab2Active Not Recruiting1
DB00073Rituximab2Completed3
DB01041Thalidomide2Completed1